Biweekly Avastin and Docetaxel as the First Line Treatment for Patients With Metastatic Breast Cancer

NCT00979641 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
65
Enrollment
OTHER
Sponsor class

Stopped Participants are no longer being examined. The results are published 2016 Anticancer Research 36: 6431-6438

Conditions

Interventions

Sponsor

Tampere University Hospital

Collaborators